Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines

Andrew S Mackie1, Wei Liu2, Anamaria Savu2

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada; Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada.

Insights

The American Heart Association

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The American Heart Association (AHA) revised infective endocarditis (IE) prophylaxis guidelines in 2007.
  • Population-based data assessing the impact of these revised guidelines were previously unavailable.
  • Understanding trends in IE hospitalizations is crucial for public health strategies.

Purpose of the Study:

  • To evaluate the impact of the 2007 American Heart Association guidelines on infective endocarditis (IE) hospitalization rates in Canada.
  • To analyze trends in IE hospitalizations before and after the guideline publication.
  • To identify changes in causative organisms and risk factors for IE.

Main Methods:

  • Utilized the Canadian Institute for Health Information Discharge Abstract Database for IE hospitalizations (April 2002–March 2013).
  • Calculated hospitalization rates using age-specific population data from Statistics Canada.
  • Employed interrupted time series analysis to assess changes in hospitalization trends post-guideline publication.

Main Results:

  • Infective endocarditis hospitalization rates increased both before and after the 2007 AHA guidelines.
  • No significant change in the slope of IE hospitalization rates was observed following the 2007 guideline release.
  • Staphylococcus aureus was the most common pathogen; pacemaker/defibrillator presence emerged as an increasing risk factor.

Conclusions:

  • The 2007 American Heart Association guidelines did not significantly alter the incidence of infective endocarditis hospitalizations in Canada.
  • IE hospitalization rates showed a continuous increasing trend, unaffected by the revised prophylaxis recommendations.
  • Further research into evolving risk factors and effective prevention strategies for IE is warranted.
Abstract

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
743
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
329
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
564
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
748
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
487